C04053-2024

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)
Jun 19, 2024
2. SEC Identification Number
148022
3. BIR Tax Identification No.
000-288-655-000
4. Exact name of issuer as specified in its charter
Euro-Med Laboratories Phil., Inc.
5. Province, country or other jurisdiction of incorporation
Metro Manila
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
PPL Building, United Nations Avenue corner San Marcelino St., Manila Postal Code 1007
8. Issuer's telephone number, including area code
00-63-2-85240091 to 98
9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares 4,112,140,540
11. Indicate the item numbers reported herein
Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 4-25 - Results of Organizational Meeting References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

Results of the Organizational Meeting of the Board of Directors

Background/Description of the Disclosure

The Board of Directors of Euro-Med Laboratories Phil., Inc. (the “Corporation”) held its Organizational Meeting today, 19 June 2024 at the Corporation’s Training Room at the 4th Floor of PPL Building, immediately after the 2024 Annual Shareholders’ Meeting.

List of elected officers for the ensuing year with their corresponding shareholdings in the Issuer
Name of Person Position/Designation Shareholdings in the Listed Company Nature of Indirect Ownership
Direct Indirect
Dr. William G. Padolina Chairman of the Board 20,564 0 -
Mr. Basilio C. Yap VIce Chairman 20,564 1,755,190 owns a share from the majority stockholder
Mr. Edwin D. Feist Vice Chairman 11,607 0 -
Mrs. Georgiana S. Evidente President 1,285,052 0 -
Dr. Johnny C. Yap Exec. Vice Pres., Treasurer, Asst. Corp. Sec. 36,980,720 568,393 owns a share from the majority stockholder
Evangeline V. Baviera, M.D. Exec. Vice President 41,645 0 -
Mrs. Janice R. Ong Corp. Sec. & Investment Relations Officer 51,410 0 -
Mr. Jose A. Emiterio Senior Vice Pres. & Compliance Officer 205,610 0 -
Mr. Enrique Raymond I. Yap Senior Vice President 16,862,581 371,844 owns a share from the majority stockholder
Mrs. Rosanna Marie S. Sunga Vice President 20,564 0 -
Mrs. Isleen Y. Sy Vice President 0 0 -
Mrs. Dinah D. Trivilegio Vice President 4,116 0 -
Mr. Virgilio V. Leyeza, Jr. Vice President 41,126 0 -
Mrs. Ma. Bernadette M. Doctor Asst. Treasurer 20,564 0 -
Atty. David Michael O. Gabriel Data Protection Officer & Legal Counsel 0 0 -
Mrs. Sandra N. Pineda Chief Accountant 0 0 -
Mrs. Evelyn O. Mangguing Internal Audit Head 0 0 -
List of Committees and Membership
Name of Committees Members Position/Designation in Committee
Corporate Governance and Nomination Committee Dr. William G. Padolina Chairman (Independent Director)
Corporate Governance and Nomination Committee Mr. Edwin D. Feist Member (Independent Director)
Corporate Governance and Nomination Committee Esperanza I. Cabral, M.D. Member (Independent Director)
Corporate Governance and Nomination Committee Dr. Johnny C. Yap Member
Corporate Governance and Nomination Committee Mrs. Georgiana S. Evidente Member
Audit and Risk Oversight Committee Mr. Edwin D. Feist Chairman (Independent Director)
Audit and Risk Oversight Committee Dr. William G. Padolina Member (Independent Director)
Audit and Risk Oversight Committee Mr. Anthony Joseph Y. Gaw Member
List of other material resolutions, transactions and corporate actions approved by the Board of Directors

None

Other Relevant Information

None

Filed on behalf by:
Name Janice Ong
Designation Corporate Secretary